Access cutting-edge large b-cell lymphoma treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Access large b-cell lymphoma specialists in Berkeley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related large b-cell lymphoma treatment provided free
This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic
Sponsor: Allogene Therapeutics
Check if you qualify for this large b-cell lymphoma clinical trial in Berkeley, CA
If you're searching for large b-cell lymphoma treatment options in Berkeley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.